We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Gynecology outpatients receiving telephone consultations (TCs) mostly describe their experience as good or very good, with positive themes including convenience and effectiveness, according to a study published online May 25 in BJOG.
AbbVie announced upadacitinib (15 mg and 30 mg, once daily) plus topical corticosteroids (TCS) met the co-primary endpoints and all secondary endpoints in AD Up, the third pivotal Phase 3 study of RINVOQ in atopic dermatitis.
There has been a large number of studies exploring the possible toxic effects of TCS on living things. The article provides some help for common health management.